Struelens Marc J, Denis Olivier, Rodriguez-Villalobos Hector
Service de Microbiologie, Microbiology Department, Université Libre de Bruxelles-Hopital Erasme, 808, route de Lennik, 1070 Brussels, Belgium.
Microbes Infect. 2004 Sep;6(11):1043-8. doi: 10.1016/j.micinf.2004.05.015.
Technological advances have expanded the role of the clinical microbiology laboratory in supporting management and control of health-care-associated infections (HAI). Diagnostic capabilities have been complemented by new methods for characterisation of microbial antigens and nucleic acids. Genomic "fingerprinting" enables the study of transmission of nosocomial pathogens. Monitoring of their antimicrobial resistance patterns has gained critical importance. However, cost-effective application of microbiological testing for improved treatment and prevention of HAI requires further study.
技术进步扩大了临床微生物学实验室在支持医疗保健相关感染(HAI)管理和控制方面的作用。诊断能力已通过微生物抗原和核酸表征的新方法得到补充。基因组“指纹识别”有助于研究医院病原体的传播。监测它们的抗菌药物耐药模式已变得至关重要。然而,为改善HAI的治疗和预防而进行的微生物检测的成本效益应用需要进一步研究。